Skip to main content
. 2020 Nov 30;18(4):484–492. doi: 10.9758/cpn.2020.18.4.484

Fig. 1.

Fig. 1

Proposed steps for the personalization of treatment in depression. Step 3 is shadowed as its possible clinical utility has not been investigated yet in the treatment of patients with depression.

PRS, polygenic risk scores; TDM, therapeutic drug monitoring; SSRIs, selective serotonin reuptake inhibitors; PMs, poor metabolizers; IMs, intermediate metabolizers; UMs, ultrarapid metabolizers.